Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine for Republic of South Africa
CEL-SCI, 03/11/09
CEL-SCI Corporation announced today that it has entered into an exclusive licensing agreement with Byron Biopharma under which CEL-SCI has granted Byron an exclusive license to market and distribute the Company's cancer drug Multikine in the Republic of South Africa. CEL-SCI already has existing licensing agreements for Multikine with Teva Pharmaceuticals and Orient Europharma.
Today in Licensure/Accreditation...keeping you current
Receive free subspecialty "5-minute updates" via email
Office Alley Gets EHNAC Accreditation
HealthDataManagement, 11/25/09
The Joint Commission Introduces Perinatal Care Core Measures
Joint Commission news, 11/24/09
Development of a Portable Linux-Based ECG Measurement and Monitoring System
The Journal of Medical Systems, 11/18/09
Article Search
Sponsor


See Latest Articles


